EUVIMEDEUVIMED entdecken
Open Access

177 Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer

Huan Du, Xiaofei Hao, Binwei Lin, Mingming Tang, Decai Wang, Xia Yang, Jing Wang, Liling Qin, Yuchuan Yang, Xiaobo Du

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.268487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Huan Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Radioisotopes, Lutetium, Antibodies, Monoclonal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsRadioisotopesLutetiumAntibodies, MonoclonalMolecular Targeted TherapyClaudinsHumansAnimalsMiceFemaleMaleCell Line, TumorTissue DistributionIsotope LabelingRetrospective StudiesMiddle AgedRadiopharmaceuticalsAgedPositron-Emission Tomography

Stichwörter der Autor:innen

177Lu89ZrCLDN6esophageal cancertargeted radiopharmaceutical therapy

Substanzen

RadioisotopesLutetiumLutetium-177Antibodies, MonoclonalClaudinsRadiopharmaceuticals

Autor:innen und Institutionen

  • Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
  • NHC Key Laboratory of Nuclear Technology Medical Transformation, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
  • Clinical Medical School, North Sichuan Medical College, Nanchong, China.
  • Sichuan Clinical Research Center for Radiation and Therapy, Mianyang Central Hospital, Mianyang, China.
  • Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, China; and.
  • Pathology Department, First People's Hospital of Mianyang, Mianyang, China.

Zitieren

APA

Du, H., Hao, X., Lin, B., Tang, M., Wang, D., Yang, X., Wang, J., Qin, L., Yang, Y., & Du, X. (2025). 177 Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268487

Vancouver

Du H, Hao X, Lin B, Tang M, Wang D, Yang X, et al. 177 Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.268487

BibTeX
@article{Du2025,
  author = {Du, Huan and Hao, Xiaofei and Lin, Binwei and Tang, Mingming and Wang, Decai and Yang, Xia and Wang, Jing and Qin, Liling and Yang, Yuchuan and Du, Xiaobo},
  title = {177 Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.268487}
}
Kostenlos starten →